EP-1621 First results of the first cohort of a phase I dose-escalation trial on SABR for oligometastases. (April 2019) - Mercier, C.; Dirix, P.; Billiet, C.; Meijnders, P.; Vermeulen, P.; Rypens, C.; Huget, P.; Verellen, D.